Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 Aug 10;21(9):547. doi: 10.1038/s41577-021-00611-1

Detecting future coronavirus pandemics

Alexandra Flemming 1,✉
PMCID: PMC8353613  PMID: 34376830

The past two decades saw several spillovers of animal coronaviruses (aCoVs) to humans. Reporting in Science Immunology, Klompus et al. investigated antibody cross-reactivity between human coronaviruses (hCoVs) and aCoVs by probing the antibody repertoires of 269 individuals who had recovered from COVID-19 against a library of ~13,000 peptides derived from all seven hCoVs and 49 aCoVs. Several broadly reactive monoclonal antibodies showed marked interspecies cross-reactivity. The authors demonstrated that antibody binding data combined with machine learning allows to accurately distinguish between individuals who had been exposed to SARS-CoV-2 and those who had not, even when SARS-CoV-2-specific peptides were excluded from the library. This suggests a potential application of similar antigen libraries for the rapid serological detection of future zoonotic spillovers.

References

Original article

  1. Klompus S, et al. Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers. Sci. Immunol. 2021 doi: 10.1126/sciimmunol.abe9950. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nature Reviews. Immunology are provided here courtesy of Nature Publishing Group

RESOURCES